• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA在前列腺癌中的新兴作用:诊断与治疗的未来时代。

Emerging role of miRNA in prostate cancer: A future era of diagnostic and therapeutics.

作者信息

Khan Mohd Mabood, Sharma Vineeta, Serajuddin Mohammad

机构信息

Department of Zoology, University of Lucknow, Lucknow 226007, Uttar Pradesh, India.

Department of Medicine, Vanderbilt University Medical Center, Nashville 37232, TN, USA.

出版信息

Gene. 2023 Dec 20;888:147761. doi: 10.1016/j.gene.2023.147761. Epub 2023 Sep 4.

DOI:10.1016/j.gene.2023.147761
PMID:37666374
Abstract

Prostate cancer (PCa) is the most common cancer in men (20%) and is responsible for 6.8% (1/5) of all cancer-related deaths in men around the world. The development and spread of prostate cancer are driven by a wide variety of genomic changes and extensive epigenetic events. Because of this, the MicroRNA (miRNA) and associated molecular mechanisms involved in PCa genesis and aggressive were only partially identified until today. The miRNAs are a newly discovered category of regulatorsthat have recently been recognized to have a significant role in regulating numerous elements of cancer mechanisms, such as proliferation, differentiation, metabolism, and apoptosis. The miRNAs are a type of small (22-24 nucleotides), non-coding, endogenous, single-stranded RNA and work as potent gene regulators. Various types of cancer, including PCa, have found evidence that miRNA genes, which are often located in cancer-related genetic regions or fragile locations, have a role in the primary steps of tumorigenesis, either as oncogenes or tumorsuppressors. To explain the link between miRNAs and their function in the initiation and advancement of PCa, we conducted a preliminary assessment. The purpose of this research was to enhance our understanding of the connection between miRNA expression profiles and PCa by elucidating the fundamental processes of miRNA expression and the target genes.

摘要

前列腺癌(PCa)是男性中最常见的癌症(占20%),在全球男性所有癌症相关死亡中占6.8%(1/5)。前列腺癌的发展和扩散是由多种基因组变化和广泛的表观遗传事件驱动的。因此,直到如今,参与前列腺癌发生和侵袭的微小RNA(miRNA)及其相关分子机制仅得到部分识别。miRNA是一类新发现的调节因子,最近人们认识到它们在调节癌症机制的众多要素(如增殖、分化、代谢和凋亡)中发挥着重要作用。miRNA是一种小的(22 - 24个核苷酸)、非编码、内源性、单链RNA,作为有效的基因调节因子发挥作用。包括前列腺癌在内的各种癌症都已发现证据表明,miRNA基因通常位于与癌症相关的遗传区域或脆弱位点,在肿瘤发生的起始步骤中作为癌基因或肿瘤抑制基因发挥作用。为了解释miRNA与其在前列腺癌起始和进展中的功能之间的联系,我们进行了一项初步评估。本研究的目的是通过阐明miRNA表达的基本过程和靶基因,增进我们对miRNA表达谱与前列腺癌之间联系的理解。

相似文献

1
Emerging role of miRNA in prostate cancer: A future era of diagnostic and therapeutics.微小RNA在前列腺癌中的新兴作用:诊断与治疗的未来时代。
Gene. 2023 Dec 20;888:147761. doi: 10.1016/j.gene.2023.147761. Epub 2023 Sep 4.
2
Role of miRNAs in prostate cancer: Do we really know everything?miRNAs 在前列腺癌中的作用:我们真的了解一切吗?
Urol Oncol. 2020 Jul;38(7):623-635. doi: 10.1016/j.urolonc.2020.03.007. Epub 2020 Apr 10.
3
miRNA in Prostate Cancer: New Prospects for Old Challenges.前列腺癌中的微小RNA:旧挑战的新前景
EJIFCC. 2014 Apr 28;25(1):79-98. eCollection 2014 Apr.
4
microRNAs as oncogenes and tumor suppressors.作为癌基因和肿瘤抑制因子的微小RNA
Dev Biol. 2007 Feb 1;302(1):1-12. doi: 10.1016/j.ydbio.2006.08.028. Epub 2006 Aug 16.
5
Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms.参与前列腺癌侵袭性和治疗抵抗机制的失调微小RNA
Cancers (Basel). 2023 Jun 10;15(12):3140. doi: 10.3390/cancers15123140.
6
Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue.系统鉴定影响前列腺癌细胞增殖并在肿瘤组织中表达改变的 microRNAs。
Eur Urol. 2016 Jun;69(6):1120-8. doi: 10.1016/j.eururo.2015.09.019. Epub 2015 Oct 20.
7
Prostate cancer small non-coding RNA transcriptome in Arabs.阿拉伯人前列腺癌的小非编码 RNA 转录组。
J Transl Med. 2017 Dec 21;15(1):260. doi: 10.1186/s12967-017-1362-x.
8
Multivariate competing endogenous RNA network characterization for cancer microRNA biomarker discovery: a novel bioinformatics model with application to prostate cancer metastasis.用于癌症微小RNA生物标志物发现的多变量竞争性内源性RNA网络特征分析:一种应用于前列腺癌转移的新型生物信息学模型
Precis Clin Med. 2022 Jan 10;5(1):pbac001. doi: 10.1093/pcmedi/pbac001. eCollection 2022 Mar.
9
miRNA and cancer; computational and experimental approaches.微小RNA与癌症;计算方法和实验方法
Curr Pharm Biotechnol. 2014;15(5):429. doi: 10.2174/138920101505140828161335.
10
Potential Urinary miRNA Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients.用于在良性前列腺增生患者中准确检测前列腺癌的潜在尿液 miRNA 生物标志物候选物。
J Cancer. 2014 Jan 29;5(3):182-91. doi: 10.7150/jca.6799. eCollection 2014.

引用本文的文献

1
MiR-135a-3p inhibits the progression of prostate cancer by targeting TLR4.微小RNA-135a-3p通过靶向Toll样受体4抑制前列腺癌进展。
Cancer Biol Ther. 2025 Dec;26(1):2545653. doi: 10.1080/15384047.2025.2545653. Epub 2025 Aug 22.
2
Current Progress and Future Perspective of Chlamydia trachomatis Infection: A Rising Threat to Women Health.沙眼衣原体感染的当前进展与未来展望:对女性健康的日益严重威胁
Curr Microbiol. 2025 May 29;82(7):314. doi: 10.1007/s00284-025-04287-x.
3
Role of circulating MicroRNAs in prostate cancer diagnosis and risk stratification in the MCC Spain study.
循环微小RNA在MCC西班牙研究中前列腺癌诊断及风险分层中的作用
Sci Rep. 2025 May 20;15(1):17517. doi: 10.1038/s41598-025-01373-9.
4
The MicroRNA miR-454 and the mediator complex component MED12 are regulators of the androgen receptor pathway in prostate cancer.微小RNA miR-454和中介体复合物成分MED12是前列腺癌雄激素受体途径的调节因子。
Sci Rep. 2025 Mar 25;15(1):10272. doi: 10.1038/s41598-025-95250-0.
5
In Silico Prediction of Maize microRNA as a Xanthine Oxidase Inhibitor: A New Approach to Treating Hyperuricemia Patients.玉米微小RNA作为黄嘌呤氧化酶抑制剂的计算机模拟预测:治疗高尿酸血症患者的新方法
Noncoding RNA. 2025 Jan 15;11(1):6. doi: 10.3390/ncrna11010006.
6
Recent progress in microRNA research for prostate cancer.前列腺癌微小RNA研究的最新进展
Discov Oncol. 2024 Sep 27;15(1):480. doi: 10.1007/s12672-024-01376-4.
7
Long Noncoding RNA MALAT1: Salt-Sensitive Hypertension.长链非编码 RNA MALAT1:盐敏感性高血压。
Int J Mol Sci. 2024 May 18;25(10):5507. doi: 10.3390/ijms25105507.
8
Role of N‑methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review).N6-甲基腺苷在前列腺癌发病机制、诊断和治疗中的作用(综述)。
Oncol Rep. 2024 Jun;51(6). doi: 10.3892/or.2024.8747. Epub 2024 May 17.
9
Integrated grade-wise profiling analysis reveals potential plasma miR-373-3p as prognostic indicator in Prostate Cancer & its target KPNA2.综合分级剖析分析揭示了血浆中潜在的miR-373-3p作为前列腺癌预后指标及其靶标KPNA2。
Noncoding RNA Res. 2024 Apr 19;9(3):954-963. doi: 10.1016/j.ncrna.2024.04.004. eCollection 2024 Sep.